Respiratory chain enzyme activities in isolated mitochondria of lymphocytes from patients with Alzheimer's disease

Neurology

Volumn 48, Issue 3, 1997, Pages 636-638

  Molina, J A ^a   De Bustos, F ^a   Jiménez Jiménez, Félix Javier ^b,d   Benito Leon J ^a   Gasalla, T ^b   Orti Pareja M ^b   Vela, L ^c   Bermejo, F ^a   Martin M A ^a   Campos, Y ^a   Arenas, J ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^c HOSPITAL DE MÓSTOLES   (Spain)

^d C/ Corregidor Jose de Pasamonte   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CITRATE SYNTHASE; CYTOCHROME C OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MITOCHONDRION; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; RESPIRATORY CHAIN;

EID: 0030945489     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.48.3.636     Document Type: Article

References (26)

1. Amaducci LA, Fratiglioni L, Rocca WA, et al. Risk-factors for clinically diagnosed Alzheimer's disease: a case-control study of an Italian population. Neurology 1986;36:922-931.
2. Shalat SL, Seltzer S, Pidcock C, Baker EL. Risk-factors for Alzheimer's disease: a case-control study. Neurology 1986;36: 1630-1633.
3. Goate AM, Hardy JA, Owen MJ, et al. Genetics of Alzheimer's disease. Adv Neurol 1990;51:197-198.
4. Spencer PS. Etiology of Alzheimer's disease: a Western Pacific view. Adv Neurol 1990;51:79-82.
5. Schapira AHV. Mitochondrial dysfunction in neurodegenerative disorders and aging. In: Schapira AHV, DiMauro S, eds. Mitochondrial disorders in neurology. Oxford: Butterworth-Heinemann, 1994:227-244.
6. Kish SJ, Bergeron C, Rajput A, et al. Brain cytochrome_oxidase in Alzheimer's disease. J Neurochem 1992;59:776-779.
7. Parker WD, Parks JK, Filley CM, Kleinschmidt-DeMasters BK Electron transport chain defects in Alzheimer's disease brain. Neurology 1994;44:1090-1096.
8. Mutisya EM, Bowling AC, Beal MF. Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. J Neurochem 1994;63:2179-2184.
9. Parker WD, Filley CM, Parks JK. Cytochrome oxidase deficiency in Alzheimer's disease. Neurology 1990;40:1302-1303.
10. Parker WD, Mahr NJ, Filley CM, et al. Reduced platelet cytochrome c oxidase activity in Alzheimer's disease. Neurology 1994;44:1086-1090.
11. Sims NR, Finegan JM, Bowen DM, Neary D. Mitochondrial function in brain tissue in primary degenerative dementia. Brain Res 1987;436:30-38.
12. Cooper JM, Wischik C, Shapira AHV. Mitochondrial function in Alzheimer's disease. Lancet 1993;341:969-970.
13. Reichman H, Florke S, Hebenstreit G, Schruber H, Riederer P. Analyses of energy metabolism and mitochodrial genome in post-mortem brain from patients with Alzheimer's disease. J Neurol 1993;240:377-380.
14. Cavelier L, Jazin EE, Eriksson I, et al. Decreased cytochrome-c oxidase activity and lack of age-related accumulation of mitochondrial DNA deletions in the brains of schizophrenics. Genomics 1995;29:217-224.
15. Van Zuylen AJ, Bosman GJCGM, Ruitenbeek W, Van Kalmthout PJC, De Grip WJ. No evidence for reduced thrombocyte cytochrome oxidase activity in Alzheimer's disease. Neurology 1992;42:1246-1247.
16. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
17. Hachinski VC, Ihift LD, Zilhka E, et al. Cerebral blood flow in dementia. Arch Neurol 1975;32:632-637.
18. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
19. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV). Washington, DC: American Psychiatric Press, 1994.
20. McKahnn G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimers disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
21. Sukava R, Haltia M, Paetau A, Wikstrom J, Palo J. Accuracy of clinical diagnosis in primary degenerative dementia: correlation with neuropathological findings. J Neurol Neurosurg Psychiatry 1983;46:9-13.
22. Martín MA, Molina JA, Jiménez-Jiménez FJ, et al. Respiratory chain enzyme activities in isolated mitochondria of lymphocytes from untreated Parkinson's disease patients. Neurology 1996;46:1343-1346.
23. Moreu E, Molinero LM, Fernández E. R-Sigma. Base de datos bioestadística para un ordenador personal. Madrid: Horus Hardware, 1990.
24. Mann VM, Cooper JM, Krige D, Daniel SE, Schapira AHV, Marsden CD. Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. Brain 1992; 115:333-342.
25. Krige D, Carroll, Cooper JM, Marsden CD, Schapira AHV. Platelet mitochondrial function in Parkinson's disease. Ann Neurol 1992;32:782-788.
26. Barroso N, Campos Y, Huertas Y, et al. Respiratory chain enzyme activities in lymphocytes from untreated patients with Parkinson's disease. Clin Chem 1993;39:667-669.